# Why Staying on Your Antidepressant Is Out of Fashion—and Also Radically OK
The cultural narrative around antidepressants has shifted dramatically. Where depression medication once carried hushed discussion and lingering stigma, a new pressure has emerged: the expectation that people should eventually taper off. Social media influencers document their journeys off SSRIs. Wellness communities celebrate antidepressant discontinuation as the logical endpoint of healing. Friends ask when you'll finally be "ready" to stop.
This framing misses something psychiatrists have long understood: for many people, staying on antidepressants long-term isn't a failure. It's a medical decision with solid science behind it.
Dr. David A. Clark, a clinical psychologist at the University of New Brunswick who specializes in mood disorders, points out that the research on antidepressant maintenance therapy is clear. People who remain on antidepressants after their initial depressive episode resolves experience significantly lower relapse rates compared to those who discontinue medication. For individuals with recurrent depression, the data favors continuation.
This doesn't mean everyone should stay on antidepressants forever. The decision to taper, maintain, or adjust dosage requires collaboration between patient and clinician, accounting for individual history, severity of depression, life circumstances, and previous episodes. Someone experiencing their first mild depressive episode linked to a specific stressor may have different needs than someone with three prior episodes and a strong genetic predisposition.
The "overprescribed" critique contains truth. Primary care physicians sometimes prescribe antidepressants without adequate follow-up or consideration of therapy alternatives. Insurance barriers often make talk therapy inaccessible while pills remain affordable. These systemic problems demand solutions.
But conflating overtreatment in some cases with the notion that antidepressants themselves are inherently overprescribed creates a false consensus. Dr. Thomas Insel, former director of the National Institute of Mental Health, has noted that depression remains undertreated in many populations, particularly among men and people of color who face cultural stigma against psychiatric medication.
The wellness movement's romanticization of being "medication-free" carries particular risk for vulnerable groups. A person may discontinue their antidepressant because social media convinced them they should be "healed by now." They relapse into severe depression. This outcome isn't enlightenment. It's preventable suffering.
Staying on an antidepressant because it works, because you feel better, because discontinuing previously threw you into crisis—these are valid reasons. They reflect informed medical decision-making, not dependence or avoidance of "real" healing.
The radical OK of this choice means accepting that mental health treatment isn't a linear journey toward independence from medication. For some people, antidepressants are like insulin for diabetes: a management tool that allows flourishing. This doesn't mean dismissing the legitimate desire some people have to discontinue medication under medical supervision, or addressing real concerns about side effects and withdrawal.
What it means is rejecting the implicit shame in questions about when you'll get off your medication. It means trusting your psychiatrist's evidence-based recommendation over your friend's social media journey. It means understanding that the strongest path forward is the one you and your doctor build together, whether that involves staying on your current medication indefinitely or carefully planning a taper. Both decisions can represent genuine healing.